It would be conflict of HIS interests to keep any clinical records or file any reports that would fast-track it to Phase III. Let's not forget that it would hurt the other company that was set up to compete with XeChem.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.